BBO-8520 Receives FDA Fast Track Designation in KRAS G12C–Mutated Metastatic NSCLC
BBO-8520 has received FDA fast track designation in previously treated KRAS G12C–mutated metastatic non–small cell lung cancer.
Related Articles
The Clinical Impact of Biased Language in Handoffs
Negative language about patients can reduce clinician empathy and recall of critical health details, a recent study finds.
Program Guide – ASCO Meeting Program Guide
Justin Miller , Alyssa Obermayer , Mitchell Hayes , Roy Elias , Nirmish Singla , Michelle Churchman , George Grass , Ahmad Tarhini , Paola…
Metabolic, cardiac, and bone health testing in patients with prostate cancer on androgen‐deprivation therapy: A population‐based assessment of adherence to therapeutic monitoring guidelines
Androgen-deprivation therapy (ADT) remains a cornerstone in treatment for patients with advanced prostate cancer and is associated with several adverse effects. Population-based assessment revealed t…
Program Guide – ASCO Meeting Program Guide
Adnan Fazili H. Lee Moffitt Cancer Center and Research Institute Adnan Fazili , Keerthi Gullapalli , Jasreman Dhillon , Carlos Segura , Jonathan Nguyen ,…
JNCCN 360 – Breast – Primary Prevention of Breast Cancer Based on AI Risk Model
By continuing to browse this site you permit us and our partner s to place identification cookies on your browser and agree to our use…
Program Guide – ASCO Meeting Program Guide
Adnan Fazili H. Lee Moffitt Cancer Center and Research Institute Adnan Fazili , Brian Morse , Abraham Ahmed , Jongphil Kim , Daniel Jeong ,…
CME / CE – Physicians’ Education Resource
Physicians’ Education Resource – Newest Continuing Medical Education Live Events, Webcasts & Online Activities
Program Guide – ASCO Meeting Program Guide
Hiroko Miyagi H. Lee Moffitt Cancer Center and Research Institute Hiroko Miyagi , Xiaoqing Yu , Taylor Peak , Jasreman Dhillon , Casey Le ,…
Program Guide – ASCO Meeting Program Guide
Jeffrey Johnson H. Lee Moffitt Cancer Center, Department of Hematology/Oncology Jeffrey Johnson , Mayer Fishman , Michael Schell , Xiaoqing Yu , Xuefeng Wang ,…
Immunosensitivity cuts across mismatch repair status in colorectal cancer
In this issue of Cancer Cell, Acha-Sagredo et al. reveal an interferon-high immunophenotype in colorectal cancer that predicts responsiveness to immune checkpoint inhibitors across both mismatch…
